# Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth

> **NCT07393802** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Baghdad** · enrollment: 20 (estimated)

## Conditions studied

- Mouthwash
- Chlorhexidine
- Biofilm Formation
- Periodontal Health

## Interventions

- **DRUG:** Resveratrol-Based Mouthwash
- **DRUG:** Chlorhexidine Gluconate 0.12 % Mouthwash
- **DRUG:** Placebo mouthwash

## Key facts

- **NCT ID:** NCT07393802
- **Lead sponsor:** University of Baghdad
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-04
- **Final completion:** 2026-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07393802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07393802, "Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07393802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
